DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > School of Medicine > Bulletin > Acta Medica Nagasakiensia > Volume 30, No. 4 >

Hepatitis B Vaccination-A Singapore Experience

File Description SizeFormat
acta30_04_07_t.pdf254 kBAdobe PDFView/Open

Title: Hepatitis B Vaccination-A Singapore Experience
Authors: Oon, Chongjin
Issue Date: 20-Mar-1986
Citation: Acta medica Nagasakiensia. 1986, 30(4), p.308-311
Abstract: A hepatitis B prevention and control programme has started in Singapore using BHepavac, an approved HB Vaccine manufactured for Singapore Biotech (Pte) by Merck Sharpe and Dohme (USA). 10 μg doses of the vaccine have been shown to be efficacious in populations under 40 years of age. In neonates, a smaller dose of 5 μg given three times at 0, 1, 2 months appears to be as effective as the 10 μg dose.
URI: http://hdl.handle.net/10069/15695
ISSN: 00016055
Type: Departmental Bulletin Paper
Text Version: publisher
Appears in Collections:Volume 30, No. 4

Citable URI : http://hdl.handle.net/10069/15695

All items in NAOSITE are protected by copyright, with all rights reserved.


Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace